5 Easy Facts About RSPO1 Protein Described
All enrolled sufferers who received no less than a single dose of zosuquidar or placebo throughout induction ended up monitored with the event of adverse situations (439 individuals, 219 on zosuquidar and 210 on placebo). The most typical adverse gatherings were being associated with the period of extended and significant myelosuppression as is ant